ClinicalTrials.gov record
Completed Phase 2 Interventional

Randomized Amifostine For SCCHN

ClinicalTrials.gov ID: NCT00095927

Public ClinicalTrials.gov record NCT00095927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck

Study identification

NCT ID
NCT00095927
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dana-Farber Cancer Institute
Other
Enrollment
58 participants

Conditions and interventions

Interventions

  • Amifostine Drug
  • Carboplatin Drug
  • Paclitaxel Drug
  • radiation Radiation

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
May 31, 2007
Completion
May 31, 2008
Last update posted
Jan 3, 2017

2003 – 2008

United States locations

U.S. sites
9
U.S. states
3
U.S. cities
7
Facility City State ZIP Site status
Goodall Hospital Sanford Maine 04703
Massachusetts General Hospital Boston Massachusetts 02114
Dana-Farber Cancer Institute Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Bethke Cancer Center at Emerson Hospital Concord Massachusetts 01742
Mass General/North Shore Cancer Center Danvers Massachusetts 01923
Saint Anne's Hospital - Fall River Fall River Massachusetts 02721
Lowell General Hospital Lowell Massachusetts 01854
Wentworth Douglass Hospital Dover New Hampshire 03820

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00095927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2017 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00095927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →